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Abstract Endoscopic retrograde cholangiography
(ERCP) is widely used as a first-line therapy for biliary
drainage. ERCP occasionally fails owing to anatomical or
technical problems, despite high reported success rates.
Endoscopic ultrasound-guided biliary drainage (EUS-BD)
has recently emerged as an effective alternative biliary
drainage method after unsuccessful ERCP. EUS-BD can be
essentially divided into 3 different techniques—(1) EUS-
guided transluminal biliary drainage including choledoco-
duodenostomy and hepaticogastrostomy, (2) EUS-rendez-
vous technique, and (3) EUS-antegrade approach. Here, we
focus on the current status of EUS-BD in light of these 3
different techniques.
Keywords Endoscopic ultrasound  Endoscopic
retrograde cholangiopancreatography  Biliary drainage 
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Introduction
Endoscopic retrograde cholangiopancreatography (ERCP)
is widely used in current medical practice as a biliary
drainage method for biliary obstruction. ERCP occasion-
ally fails owing to anatomical or technical problems such
as upper intestinal obstruction, surgically altered anatomy,
periampullary diverticulum, or periampullary tumor infil-
tration, despite a [90 % success rate in most reports.
Percutaneous transhepatic biliary drainage (PTBD) or
surgical interventions are conventionally performed as
alternative biliary drainage methods after unsuccessful
ERCP. However, both PTBD and surgical interventions
are associated with considerable morbidity and mortality
[1–3].
Endoscopic ultrasound-guided biliary drainage (EUS-
BD) was first reported in 2001 by Giovannini et al. [4].
Following this report, many groups reported the efficacy of
EUS-BD as an alternative biliary drainage method after
unsuccessful ERCP. Reported EUS-BD procedures are
divided into 3 techniques—(1) EUS-guided transluminal
biliary drainage including choledocoduodenostomy (EUS-
CDS) and hepaticogastrostomy (EUS-HGS), (2) EUS-ren-
dezvous technique (EUS-RV), and (3) EUS-antegrade
approach (EUS-AG). Here, we focus on the status of EUS-
BD in light of these 3 different techniques.
EUS-transluminal biliary drainage
Summary of the procedure
In EUS-transluminal biliary drainage, the biliary duct is
accessed under EUS guidance followed by guidewire
placement and fistula dilation. A stent is then deployed
between the biliary duct and intestine to create a permanent
fistula for biliary drainage. This procedure can be per-
formed in patients with either endoscopically accessible or
inaccessible papilla; however, its indication should be
limited in cases of unresectable malignant biliary
obstruction, given the feature of permanent fistula creation.
Actual technique
For EUS-transluminal biliary drainage, the biliary duct is
punctured from the upper intestine under EUS guidance
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followed by cholangiography to ensure proper puncture of
the biliary duct and delineate its configuration. A guidewire
is then placed into the biliary system and dilation of the
needle tract is performed. In this step, a fine needle aspi-
ration (FNA) needle, needle knife, or fistulotome can be
used for bile duct puncture with fistula creation performed
using a bougie dilator, needle knife, balloon, stent retriever,
or diathermic sheath over the guidewire. Finally, a stent is
deployed at the fistula between the biliary duct and the
intestine for biliary drainage. In terms of access route, this
technique is divided further into HGS, in which the fistula
is made between the stomach and intrahepatic bile duct
(IHBD) of the left lobe, and CDS, in which the fistula is
created between the duodenal bulb (D1) and extrahepatic
bile duct (EHBD) (Fig. 1).
Literature review and assessment
Since the first report of EUS-CDS in 2001 by Giovannini
et al. [4], multiple groups reported the efficacy of EUS-
CDS and HGS as alternative drainage methods to PTBD or
surgery after unsuccessful ERCP. Published data for EUS-
CDS and HGS show overall technical success rates of 94
and 87 % with overall early complication rates of 19 and
27 %, respectively [4–40] (Tables 1, 2). The published
overall technical success rates are similarly high for both
techniques, although various biliary access and fistula
dilation methods are used depending on preference of each
institution and endoscopist. Regarding stents, there is a
tendency to use a covered self-expandable metallic stent
(CMS), instead of a plastic stent (PS), especially in later
studies. Performing CMS placement to maintain the fistula
for bile drainage is sensible, as a CMS can potentially
prolong the stent patency period compared with a PS.
Furthermore, radial expansion of a CMS can, hypotheti-
cally, minimize the possibility for complications such as
bile peritonitis or pneumoperitoneum because the fistula is
immediately sealed by the CMS itself. However, stent
migration is a serious complication that can still occur even
with the use of a CMS, especially soon after the procedure.
Development of specially designed stents for these proce-
dures and further assessment of the methodology of biliary
access and fistula dilation are mandatory for generalization
of EUS-CDS and HGS.
EUS-rendezvous technique
Summary of the procedure
In EUS-RV, the biliary duct is accessed under EUS and
fluoroscopic guidance with the creation of a temporary
fistula followed by guidewire placement via the biliary duct
and ampulla into the duodenum. After guidewire place-
ment, ERCP is re-attempted using the EUS-placed guide-
wire. The guidewire is removed once biliary cannulation is
obtained. Therefore, EUS-RV should be attempted for
patients with an endoscopically accessible ampulla after
failed biliary cannulation in conventional ERCP.
Actual technique
After failed biliary cannulation in ERCP, a duodenoscope
is exchanged for a linear EUS scope. The biliary system is
visualized from the stomach or duodenum with color
Doppler to detect any vessels interposing on the puncture
route. The bile duct is then punctured using an FNA needle,
in which the stylet is removed and the contrast is primed,
followed by guidewire placement into the biliary sys-
tem through the needle after confirmation of proper punc-
ture of bile duct with cholangiogram. Either a 19- or
22-gauge (G) FNA needle can be used for EUS-RV. A
19-G needle allows a guidewire of up to 0.035 inches to
pass through the needle, whereas a 22-G needle only allows
a 0.018-inch guidewire to pass through. The guidewire is
then manipulated into the duodenum via the obstruction
and the ampulla. After the needle is withdrawn inside the
outer sheath, the EUS scope and needle are removed while
maintaining the guidewire in place. The duodenoscope is
reinserted along with the EUS-placed guidewire to the
ampulla, where the EUS-placed guidewire exits from the
biliary orifice. Biliary cannulation is reattempted along
with the guidewire. As another means of obtaining biliary
cannulation, the distal end of the guidewire is grasped with
Fig. 1 Access routes of endoscopic ultrasound-guided transluminal
biliary drainage. 1 Hepaticogastrostomy; 2 choledocoduodenostomy
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Giovannini et al. [4] CDS (1) NK BD PS 100 (1/1) 0 (0/1) None
Burmester et al. [5] CDS (2) Fistulotome None PS 50 (1/2) 50 (1/2) Bile peritonitis 1
Puspok et al. [6] CDS (5) NK None PS 80 (4/5) 0 (0/5) None
Yamao et al. [7] CDS (2) NK BD PS 100 (2/2) 0 (0/2) None
Fujita et al. [8] CDS (1) 19G BD PS 100 (1/1) 0 (0/1) None
Ang et al. [9] CDS (2) 19G NK, BD PS 100 (2/2) 50 (1/2) Pneumoperitoneum 1
Tarantino et al. [10] CDS (4) 19G, 22G NK, balloon PS 100 (4/4) 0 (0/4) None
Yamao et al. [11] CDS (5) NK BD PS 100 (5/5) 20 (1/5) Pneumoperitoneum 1
Itoi et al. [12] CDS (4) 19G, NK BD PS,
NBD
100 (4/4) 25 (1/4) Bile peritonitis 1
Brauer et al. [13] CDS (3) 19G, 22G NK PS 100 (3/3) 33 (1/3) Pneumoperitoneum 1
Horaguchi et al. [14] CDS (8) 19G BD, balloon PS,
NBD
100 (8/8) 13 (1/8) Peritonitis 1
Hanada et al. [15] CDS (4) 19G BD PS 100 (4/4) 0 (0/4) None
Park et al. [16] CDS (4), CGS
(1)
19G NK, BD CMS 100 (5/5) 0 (0/5) None
Iwamuro et al. [17] CDS (5) NK BD PS 100 (5/5) 20 (1/5) Severe abdominal pain
and fever 1
Siddiqui et al. [18] CDS (8) 19G NK CMS 100 (8/8) 25 (2/8) Duodenal perforation 1,
abdominal pain 1
Belletrutti et al. [19] CDS (4) 19G Balloon PS,
CMS
100 (4/4) 0 (0/4) None
Hara et al. [20] CDS (18) NK BD PS 94 (17/18) 17 (3/18) Peritonitis 2, hemobilia
1





CDS (9) 19G NK, BD, balloon PS 89 (8/9) 11 (1/9) Biloma
Park et al. [23] CDS (24) 19G NK, BD PS,
CMS
92 (24/26) 19 (5/26) n/a
Fabbri et al. [24] CDS (15) 19G NK, balloon CMS 80 (12/15) 7 (1/15) Pneumoperitoneum 1
Kawakubo et al. [25] CDS (1) 19G BD, balloon PS 100 (2/2) 0 (1/1) None
Katanuma et al. [26] CDS (1) 19G NK, BD PS 100 (1/1) 0 (0/1) None
Attasaranya et al.
[27]
CDS (9) 19G BD PS,
CMS
56 (5/9) 44 (4/9) n/a
Artifon et al. [28] CDS (13) 19G NK, BD CMS 100 (13/13) 15 (2/13) Bleeding 1, bile leak 1
Kim et al. [29] CDS (9) 19G NK, BD CMS 100 (9/9) 50 (5/10) Pneumoperitoneum 2,
migration 2,
peritonitis 1
Song et al. [30] CDS (15) 19G NK, BD CMS 87 (13/15) 23 (3/15) Pneumoperitoneum 2,
cholangitis 1
Vila et al. [31] CDS (26) n/a n/a n/a 86 (19/26) 15 (4/26) Biloma 1, bleeding 1,
pancreatitis 1,
cholangitis 1
Tonozuka et al. [32] CDS (4) CGS
(1)
19G BD, balloon, DS CMS 100 (5/5) 0 (0/5) None
Khashab et al. [33] CDS (15) 19G, 22G BD, balloon PS,
CMS
100 (20/20) n/a (n/a) n/a
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forceps or a snare and the guidewire is pulled out through
the mouth with the scope or through its accessory channel.
An ERCP cannula inserted over the guidewire or the
duodenoscope is back-loaded over the guidewire and re-
advanced to the ampulla if the guidewire is pulled out
through the mouth. Finally, endoscopic biliary stenting is
accomplished as planned.
Literature review and assessment
Published EUS-RV data are shown in Table 3 [10, 33, 41–
51]. The overall success rate of EUS-RV is 81 % with a
complication rate of 10 %. One of the most challenging
aspects of EUS-RV is guidewire manipulation, in which the
guidewire has to pass through the long rigid needle, biliary
ducts, obstruction, and ampulla [52]. EUS-RV can be
divided into IHBD and EHBD approaches. The EHBD
approach can be performed with 2 scope positions, the push
(long) and pull (short) positions, in terms of the scope
shapes during EUS-RV (Table 4). In the IHBD approach,
the biliary duct can be accessed from the stomach using the
straight scope position, which eases needle maneuverabil-
ity, although correct biliary puncture may be difficult in
patients with insufficient IHBD dilation. Furthermore, the
longer distance between the access point and the ampulla
decreases the pushability and torque transmission of the
guidewire needed to pass though the downstream resis-
tance. In the EHBD approach using the push scope position,
the distance between the access point and the ampulla is
short because the EHBD is punctured from D1; however,
the loop of the scope inside the stomach may impair
maneuverability of the needle, and access to the EHBD with
the needle directed toward the hepatic hilar makes guide-
wire manipulation toward the ampulla side difficult. On the
other hand, in the EHBD approach using the pull scope
position, biliary access is made with a very short distance
and needle direction toward the ampulla. However, this
approach might be difficult in patients with distal bile duct
obstruction, such as those with pancreatic head cancer,
because the scope position might be lost from D2 when the
scope is pulled to puncture the EHBD above the obstruc-
tion. Some groups prefer the IHBD approach, as it is con-
sidered to have a lower risk of bile leakage than the EHBD
approach [44, 47]. Theoretically, the IHBD approach may
reduce the risk of bile leakage because the liver parenchyma
around the bile duct can tamponade the temporal fistula.
However, we believe that selection of approach routes that
maximize the success rate is the most important factor to
reduce the complications associated with bile leakage, as
proper biliary drainage can reduce bile leakage and treat
bile peritonitis. Careful selection of the biliary duct access
point and scope position for feasible guidewire manipula-
tion with consideration of the aforementioned factors is
important to assure successful EUS-RV.
EUS-guided antegrade treatments
Summary of the procedure
In EUS-AG, the IHBD is accessed from the upper intestine
with creation of a temporary fistula between the intestine
and IHBD. After dilation of the fistula, stent placement or
balloon dilation are performed for biliary obstruction
through the fistula without the endoscope reaching the
ampulla. This technique is suitable for biliary obstruction
in patients with surgically altered anatomy or upper intes-
tinal obstruction, in which reaching the biliary orifice
endoscopically is impossible or cumbersome.
Actual technique
After careful examination of the left lobe of the liver using
color Doppler to detect any interposing vessels, the IHBD
is punctured from the intestine using an FNA needle
























Hara et al. [35] CDS (18) NK BD CMS 94 (17/18) 11 (2/18) Peritonitis 2
Overall 94 (282/300) 19 (53/280)
CDS choledocoduodenostomy, CGS choledocogastrostomy, 19G 19-gauge FNA needle, 22G 22-gauge FNA needle, NK needle knife, CN
coagulation needle, SR stent retriever, DS diathermic sheath, PS plastic stent, CMS covered self-expandable metallic stent
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confirmed with bile aspiration and cholangiography
through the needle. A guidewire is then inserted into the
biliary system through the needle followed by removal of
the needle and dilation of the fistula using a bougie dilator
over the guidewire. The guidewire is then manipulated into
the intestine through the ampulla or anastomosis, with
coordinated movements of the guidewire and dilator inside
the biliary system. A self-expandable metallic stent is
deployed to the malignant biliary obstruction or balloon
dilation is performed for a benign biliary stricture in an
antegrade fashion. Finally, all devices are removed after
confirmation that bile flows well through the stent or
stricture.
Literature review and assessment
Only several reports exist regarding one-step EUS-AG.
The overall success and complication rates of EUS-AG are
77 and 5 %, respectively [47, 51, 53–56] (Table 5). EUS-
AG also requires complicated guidewire manipulation,
















HGS (1), HJS (1) Fistulotome None PS 100 (2/2) 0 (0/2) None
Giovannini et al.
[36]
HGS (1) 19G NK PS 100 (1/1) 0 (0/1) None
Artifon et al. [37] HGS (1) 19G BD, balloon CMS 100 (1/1) 0 (0/1) None
Will et al. [38] HES (1), HGS (4),
HJS (3)
19G BD, balloon PS,
CMS
88 (7/8) 25 (2/8) Cholangitis and pain 1, pain 1
Bories et al. [39] HGS (11) 19G, 22G Cystotome PS,
CMS
91 (10/11) 36 (4/11) Early stent occlusion 1,
transient ileus 1, biloma 1,
cholangitis 1
Park et al. [16] HGS (8), HES (1) 19G BD, NK CMS 100 (9/9) 22 (2/9) Pneumoperitoneum 2
Iwamuro et al.
[17]
HGS (2) NK BD PS 100 (2/2) 50 (1/2) Bile leak and
pneumoperitoneum 1
Park et al. [40] HGS (5) NK BD CMS 100 (5/5) 0 (0/5) None
Belletrutti et al.
[19]
HGS (3) 19G Balloon PS,
CMS
67 (2/3) 0 (0/3) None
Ramirez-Luna
et al. [22]
HGS (2) 19G NK, BD PS 100 (2/2) 50 (1/2) Stent migration 1
Park et al. [23] HGS (31) 19G NK, BD PS,
CMS
100 (31/31) 19 (6/31) n/a
Fabbri et al. [24] HGS (1) 19G NK,
balloon
CMS 0 (0/1) 0 (0/1) None
Attasaranya et al.
[27]
HGS (16) 19G BD PS,
CMS
81 (13/16) 38 (6/16) n/a
Kim et al. [29] HGS (4) 19G NK, BD CMS 75 (3/4) 50 (2/4) Abdominal pain 1, stent
migration 1
Vila et al. [31] HGS (34) n/a n/a n/a 65 (22/34) 29 (11/34) Biloma 3, bleeding 3,




HGS (3) 19G BD,
balloon,
CN
CMS 100 (3/3) 0 (0/3) None
Khashab et al.
[33]
HGS (3), HES (2) 19G, 22G BD, balloon PS,
CMS
100 (5/5) n/a (n/a) n/a
Kawakubo et al.
[34]





95 (19/20) 30 (6/20) Bile leak 2, stent misplacement
2, bleeding 1, cholangitis 1,
biloma 1
Overall 87 (137/158) 27 (41/153)
HGS hepaticogastrostomy, HJS hepaticojejunostomy, HES hepaticoesophagostomy, 19G 19-gauge FNA needle, 22G 22-gauge FNA needle, NK
needle knife, CN coagulation needle, PS plastic stent, CMS covered self-expandable metallic stent
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similar to EUS-RV in which the guidewire has to be placed
through the FNA needle, via the biliary duct, obstruction,
and ampulla, into the duodenum. However, in EUS-AG,
the guidewire can be manipulated with coordinated
movement of the catheter inside the biliary duct, like
PTBD, once the fistula is dilated with a bougie dilator. On
the other hand, a major concern in EUS-AG is the possi-
bility of bile leakage into the peritoneal cavity through the
temporally dilated fistula after the procedure. In the re-
viewed literatures, however, no cases of biliary peritonitis
have been reported, although further study is needed to
evaluate possible complications.
Table 3 Published data on EUS-guided rendezvous technique
References EHBD approach IHBD approach Overall Complications, n
Success rate, % (n) Success rate, % (n) Success rate, % (n) Complication
rate, % (n)
Tarantino et al. [10] 50 (4/8) – 50 (4/8) 13 (1/8) Death due to LC 1
Maranki et al. [42, 44, 45]c 57 (8/14)a 65 (26/40)a 63 (34/49)a 16 (8/49) Abdominal pain 1,
pneumoperitoneum 4,
bleeding 1, biliary peritonitis
1, aspiration pneumonia 1
Kim et al. [41, 43, 46]c 80 (12/15) – 80 (12/15) 13 (2/15) Sepsis 1, pancreatitis 1
Shah et al. [47] n/a (n/a) n/a (n/a) 74 (37/50) 8 (4/50) Pancreatitis 2, bile leak 1,
perforation 1
Iwashita et al. [48] 81 (25/31) 44 (4/9) 73 (29/40) 13 (5/40) Abdominal pain 1, pancreatitis
2, pneumoperitoneum 1,
sepsis/death 1b
Dhir et al. [49] 98 (57/58) – 98 (57/58) 3 (2/58) Extravasation of contrast 2
Kawakubo et al. [50] 100 (9/9) 100 (5/5) 100 (14/14) 14 (2/14) Pancreatitis 1, bile peritonitis 1
Park et al. [51] 93 (13/14) 50 (3/6) 80 (16/20) 10 (2/20) Pancreatitis 1, bile peritonitis 1
Khashab et al. [33] 100 (11/11) 100 (2/2) 100 (13/13) 15 (2/13) Pancreatitis 1, cholecystitis 1
Overall 87 (139/160) 65 (40/62) 81 (215/267) 11 (24/217)
EHBD extra hepatic bile duct, IHBD intra-hepatic bile duct, LC liver cirrhosis
a Including 5 patients converted from IHBD approach
b Assessed unrelated to the procedure
c Overlapping references
Table 4 Comparison of approach routes during EUS-rendezvous technique
IHBD EHBD
Scope position Straight Push (long) Pull (short)
Schema
Puncture site Stomach D1 D2
Scope stability Stable Stable Unstable
Needle maneuverability Easy Difficult Normal
Diameter of bile duct Small Large Large
Needle direction Ampulla Hepatic hilar Ampulla
Distance to papilla Long Short Very short
IHBD intra hepatic bile duct, EHBD extra hepatic bile duct, D1 duodenal bulbs, D2 2nd portion of the duodenum
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Selection of techniques in EUS-guided biliary drainage
All 3 EUS-BD techniques require an experienced endos-
copist in both the EUS and ERCP procedures as well as the
capability of EUS and fluoroscopy. Availability of alter-
native biliary decompression, such as PTBD or surgery, is
also critical to minimize the risk of bile leakage into the
peritoneal cavity in preparation for unsuccessful EUS-BD.
The indication for EUS-BD should be decided carefully by
taking into account the condition and needs of the patient
as well as the endoscopist and facilities available.
Once the decision to perform EUS-BD is made, selec-
tion of situation-specific EUS-BD techniques should be
made, although each EUS-BD technique has overlapping
indications and there is no guideline for selection of tech-
niques. Khashab et al. [33] compared outcomes of EUS-RV
and EUS-transluminal biliary drainage using a standard-
ized approach, in which EUS-RV is initially attempted if
the ampulla is accessible, followed by EUS-transluminal
biliary drainage as a salvage procedure for cases of
unsuccessful guidewire placement into the intestine; EUS-
transluminal biliary drainage is the first option if the
ampulla is inaccessible. Their results suggested that both
techniques seem to be equally effective and safe with their
standardized approach and EUS-transluminal biliary
drainage is a reasonable alternative to EUS-RV. Park et al.
[51] also conducted a study using their treatment procedure
with an enhanced guidewire manipulation protocol
including EUS-RV for patients with an accessible ampulla
or EUS-AG for patients with surgically altered anatomy.
EUS-AG was considered a first-line intervention for
patients with an inaccessible ampulla after failed ERCP,
with the exception of patients with duodenal invasion. For
patients with duodenal invasion, EUS-transluminal biliary
drainage was performed after duodenal stent placement, as
ampullary access and transampullary drainage are impos-
sible. In this study, a favorable success rate and acceptable
adverse event rate were achieved with their enhanced
procedure. As these two studies indicated, it might be
important to apply different EUS-BD techniques depending
on patient condition and progress of the procedure.
Given the results of previous studies regarding EUS-BD,
our proposed treatment algorithm using EUS-BD after
unsuccessful ERCP is shown in Fig. 2. EUS-RV can be a
first-line EUS-BD technique in patients with an endo-
scopically accessible ampulla. If endoscopic access to the
ampulla is impossible or difficult (e.g., surgically altered
anatomy), EUS-AG is a suitable option. EUS-CDS and
HGS can be used for either an accessible or inaccessible
ampulla, but have a good indication for an ampulla with
tumor invasion. If all EUS-guided managements fail,
PTBD or surgery should be considered the next step to
minimize potential complications.
Conclusion
EUS-BD is a feasible salvage technique for unsuccessful
ERCP, although further studies are needed to compare the
efficacy and safety between EUS-BD and PTBD and to
examine a treatment procedure using EUS-BD techniques.
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100 (5/5) 0 (0/5) None
Artifon et al. [54] 100 (1/1) 0 (0/1) None
Park et al. [55] 100 (1/1) 0 (0/1) None
Shah et al. [47] 81 (13/16) 6 (1/16) Hepatic
hematoma 1
Iwashita et al. [56] 100 (2/2) 50 (1/2) Pancreatitis 1
Park et al. [51] 57 (8/14) 0 (0/14) None
Overall 77 (30/39) 5 (2/39)
Fig. 2 Proposed treatment procedure using endoscopic ultrasound-
guided biliary drainage after unsuccessful endoscopic retrograde
cholangiography
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